| Biomarker ID | 552 |
| PMID | 20973404 |
| Year | 2010 |
| Biomarker | Total sialic acid |
| Biomarker Basis | Concentration Based (mg/dL) |
| Biomolecule | Metabolites |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated (mg/dL): (BPH: 7.24±4.56) Vs (Prostate Cancer: 15.1±4.83) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include: Organic anion transporters,Amino acid and oligopeptide SLC transporters, Transport of inorganic cations/anions and amino acids/oligopeptides,Lysosome, SLC-mediated transmembrane transport |
| Experiment | BPH Vs Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 50 patients as controls, 75 with BPH and 100 with Prostate Cancer were chosen for the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | SLC17A5 |